Moreover, previously, ELOVL5 and IGFBP6 genes seemed to be unrelated to each other, and the reason for the observed synergism of the levels of expression of these two genes in the prediction of BC relapse was unclear. The gene discussed is ELOVL5; the disease is breast cancer.